AbbVie (NYSE:ABBV) Given "Sell" Rating at BMO Capital Markets

MAI Capital Management now owns 44,915 shares of the company's stock valued at $4,344,000 after buying an additional 7,048 shares during the period. The institutional investor held 10,590 shares of the major pharmaceuticals company at the end of 2017Q4, valued at $1.02 million, up from 4,668 at the end of the previous reported quarter. Tesla Inc now has $50.73 billion valuation. The stock decreased 0.36% or $0.35 during the last trading session, reaching $96.28. (NYSE:BKD) has declined 47.17% since April 15, 2017 and is downtrending. It has underperformed by 3.88% the S&P500. Neville Rodie & Shaw Inc sold 4,650 shares as the company's stock declined 6.31% with the market. Weight Watchers Intl Inc New (NYSE:WTW) was raised too. Zacks Investment Research downgraded AbbVie from a "buy" rating to a "hold" rating in a research report on Monday, January 22nd. The firm earned "Market Perform" rating on Monday, January 4 by Wells Fargo. Finally, Leerink Swann set a $106.00 target price on shares of AbbVie and gave the stock a buy rating in a research report on Tuesday, December 5th. The stock of eBay Inc. The rating was upgraded by Citigroup to "Buy" on Tuesday, August 8. The stock has "Buy" rating by Jefferies on Monday, February 26. As per Wednesday, June 8, the company rating was downgraded by Morgan Stanley. On Tuesday, August 11 the stock rating was upgraded by TheStreet to "Buy". BMO Capital Markets has "Underperform" rating and $80 target. The firm has "Hold" rating given on Thursday, October 19 by Jefferies.

Since October 23, 2017, it had 0 insider purchases, and 11 selling transactions for $70.30 million activity. (NASDAQ:FB) to report earnings on May, 2. (NYSE:ABBV) shares. On Wednesday, February 28 the insider SALEKI-GERHARDT AZITA sold $157,458.

AbbVie announced that its Board of Directors has initiated a share buyback program on Thursday, February 15th that permits the company to repurchase $10.00 billion in shares.

Investors sentiment decreased to 1.05 in 2017 Q4. This is a positive change from AbbVie's previous quarterly dividend of $0.71. EPS is an indicator of company profit because the more earnings a company can generate per share, the more valuable each share is to investors. 81 funds opened positions while 215 raised stakes. Tci Wealth Advisors reported 0.84% in AbbVie Inc. Marshwinds Advisory Co invested in 32,358 shs. (NASDAQ:TSLA). 655,149 were accumulated by Century. Tarbox Family Office stated it has 9 shares or 0% of all its holdings. Calamos Wealth Mngmt Ltd Llc owns 14,246 shares or 0.18% of their USA portfolio. Aull & Monroe Investment Management holds 1.42% or 29,124 shs. Ironwood Fin Limited Liability Company holds 0.01% or 214 shares. Fayerweather Charles invested in 6,484 shares or 0.92% of the stock. Stockholders of record on Friday, April 13th will be issued a $0.96 dividend.

Investors sentiment decreased to 0.8 in 2017 Q4. Its down 0.05, from 0.85 in 2017Q3.

A number of large investors have recently bought and sold shares of ABBV. Sterling Capital Management Llc who had been investing in Abbvie Inc Com for a number of months, seems to be less bullish one the $145.71B market cap company. (NYSE:ABBV). Private Ocean Lc holds 0.07% or 1,271 shs in its capital. Panagora Asset has 0.02% invested in eBay Inc. (NYSE:UPS). Paloma Prns Mgmt, a Connecticut-based fund reported 78,273 shares. Nebraska-based Pittenger Anderson has invested 0.09% in AbbVie Inc. Beaton Management Co. Inc. bought a new position in AbbVie in the 2nd quarter worth approximately $528,000. (NYSE:ABBV) rating on Thursday, November 16. (NYSE:HCA) for 10,775 shares. 280 were reported by Barnett &.

On a weekly basis, the stock is -0.10%. Timber Hill Ltd Com holds 0.13% or 21,391 shares. Delphi Mgmt Inc Ma has invested 1.53% of its portfolio in AbbVie Inc. (NYSE:ABBV). 170,485 were accumulated by Oregon Pub Employees Retirement Fund. Dowling & Yahnke Ltd Liability Corporation reported 75,657 shares. It also increased its holding in Alphabet Class A by 444 shares in the quarter, for a total of 14,851 shares, and has risen its stake in United Technologies Corp (NYSE:UTX).

ABBV registered $49.35 million net activity with 0 buys and 12 insider sales since October 30, 2017. $2.24M worth of HCA Healthcare, Inc. (NYSE:ABBV) was sold by Gosebruch Henry O. RUTHERFORD BILL B had sold 48,462 shares worth $4.96M on Wednesday, January 31. 83,574 shares were sold by ALBAN CARLOS, worth $9.57 million. (NYSE:ABBV) to report earnings on April, 26. $2.61M worth of eBay Inc. The insider Michael Robert A. sold 992 shs worth $119,351. Over the last quarter, insiders have sold 211,197 shares of company stock valued at $24,585,575. HCA Healthcare, Inc. (NYSE:HCA) has risen 7.67% since April 15, 2017 and is uptrending. During the same period in the prior year, the company earned $1.20 earnings per share. DE's profit will be $1.09B for 11.16 P/E if the $3.36 EPS becomes a reality. After $1.48 actual EPS reported by AbbVie Inc. for the previous quarter, Wall Street now forecasts 20.27% EPS growth. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating, eight have given a buy rating and two have issued a strong buy rating to the stock. Therefore 42% are positive.

Productivity proportions: Investigating the productivity proportions of AbbVie Inc. stock, the speculator will discover its ROE, ROA, ROI remaining at 92.7%, 7.8%, and 25.4%, individually. Jefferies maintained it with "Buy" rating and $130.0 target in Tuesday, January 16 report. The firm has "Buy" rating given on Wednesday, September 20 by Oppenheimer. On Thursday, March 22 the firm earned "Hold" rating by Bernstein. Credit Suisse Group set a $98.00 target price on AbbVie and gave the stock a "hold" rating in a research note on Monday, January 22nd. Stifel Nicolaus maintained the stock with "Hold" rating in Friday, October 27 report. AbbVie now has a consensus rating of "Buy" and a consensus target price of $117.85. The company presently has a consensus rating of Hold and a consensus target price of $69.90.